{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:58:41Z","timestamp":1781643521329,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270109"],"award-info":[{"award-number":["82270109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Scholars Program","award":["048"],"award-info":[{"award-number":["048"]}]},{"name":"Reform and Development Program of Beijing Institute of Respiratory Medicine","award":["Ggyfz202502"],"award-info":[{"award-number":["Ggyfz202502"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant pleural effusion (MPE), a common complication of advanced cancers, is associated with poor prognosis and reduced quality of life. Although host\u2013tumor interactions are known to drive MPE development, the associated immune dynamics during disease progression remain unclear. Using a Lewis lung carcinoma-induced MPE model in C57BL\/6JNidfc mice, we systematically evaluated general parameters and immune cell changes at two-day intervals throughout disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The day of Lewis lung carcinoma cell injection into the pleural space was designated as day 0. By day 10 post-injection (p.i.), MPE-bearing mice exhibited\u2009~\u200910% body weight loss, marking the experimental endpoint. Pleural tumor mass and pleural effusion volume were minimal up to day 4 p.i. but increased sharply from day 6 onward. CD45\u207a immune cell counts rose over time, and days 6, 8, and 10 p.i. marked key stages of MPE progression. On day 6, B cells, T cells, and natural killer cells, but not macrophages and neutrophils, increased significantly compared to earlier timepoints. By day 8, all immune cell subsets except T cells exceeded day 6 levels, and at day 10, natural killer cell numbers declined while others continued to increase. Besides, the numbers of CD8\u207a T cells, Th1 cells, regulatory T cells, and M2 macrophages progressively increased from day 6 to 10. Based on these data, days 6 and 10 were defined as early and advanced MPE stages, respectively, with distinct immune phenotypes. In advanced MPE, CD8\u207a T cells displayed reduced IFN-\u03b3, TNF-\u03b1, Granzyme B, Perforin, FasL, and Ki-67, but upregulated PD-1 and CTLA-4 relative to early stage. Similarly, Th1 cells showed decreased IFN-\u03b3, TNF-\u03b1, and IL-2 production along with reduced Ki-67 expression. Advanced-stage M2 macrophages exhibited lower MHC-II levels and impaired phagocytosis, but higher PD-L1 and IL-10 production, while neutrophils showed reduced TNF-\u03b1 release and phagocytic activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings characterize the temporal immune dynamics associated with MPE progression in a mouse model, revealing a transition from an early immunostimulatory state to a late immunosuppressive state. This study enhances our understanding of MPE immunopathogenesis and provides a foundation for developing precise, stage-specific therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42826-026-00268-8","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T06:25:21Z","timestamp":1774333521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunodynamic changes in a mouse model of malignant pleural effusion"],"prefix":"10.1186","volume":"42","author":[{"given":"Xiao-Lei","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Zhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6495-3690","authenticated-orcid":false,"given":"Kan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"issue":"8","key":"268_CR1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1056\/NEJMra1403503","volume":"378","author":"D Feller-Kopman","year":"2018","unstructured":"Feller-Kopman D, Light R. Pleural Disease. N Engl J Med. 2018;378(8):740\u201351.","journal-title":"N Engl J Med"},{"issue":"4","key":"268_CR2","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.chest.2016.11.010","volume":"151","author":"N Taghizadeh","year":"2017","unstructured":"Taghizadeh N, Fortin M, Tremblay A. US Hospitalizations for Malignant Pleural Effusions: Data From the 2012 National Inpatient Sample. Chest. 2017;151(4):845\u201354.","journal-title":"Chest"},{"issue":"Suppl 2","key":"268_CR3","doi-asserted-by":"publisher","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","volume":"65","author":"ME Roberts","year":"2010","unstructured":"Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii32\u201340.","journal-title":"Thorax"},{"issue":"9","key":"268_CR4","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1200\/JCO.2013.50.5453","volume":"32","author":"JS Ryu","year":"2014","unstructured":"Ryu JS, Ryu HJ, Lee SN, Memon A, Lee SK, Nam HS, et al. Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol. 2014;32(9):960\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"268_CR5","doi-asserted-by":"publisher","first-page":"100349","DOI":"10.1016\/j.opresp.2024.100349","volume":"6","author":"A Pardessus Otero","year":"2024","unstructured":"Pardessus Otero A, Rafecas-Codern A, Porcel JM, Serra-Mitj\u00e0 P, Ferreiro L, Botana-Rial M, et al. Malignant Pleural Effusion: A Multidisciplinary Approach. Open Respir Arch. 2024;6(4):100349.","journal-title":"Open Respir Arch"},{"issue":"4","key":"268_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017;168(4):707\u201323.","journal-title":"Cell"},{"issue":"4","key":"268_CR7","doi-asserted-by":"publisher","first-page":"e1554969","DOI":"10.1080\/2162402X.2018.1554969","volume":"8","author":"P Murthy","year":"2019","unstructured":"Murthy P, Ekeke CN, Russell KL, Butler SC, Wang Y, Luketich JD, et al. Making cold malignant pleural effusions hot: driving novel immunotherapies. Oncoimmunology. 2019;8(4):e1554969.","journal-title":"Oncoimmunology"},{"issue":"6","key":"268_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1164\/rccm.201203-0465PP","volume":"186","author":"GT Stathopoulos","year":"2012","unstructured":"Stathopoulos GT, Kalomenidis I. Malignant pleural effusion: tumor-host interactions unleashed. Am J Respir Crit Care Med. 2012;186(6):487\u201392.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"268_CR9","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1038\/s41467-021-27026-9","volume":"12","author":"ZY Huang","year":"2021","unstructured":"Huang ZY, Shao MM, Zhang JC, Yi FS, Du J, Zhou Q, et al. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion. Nat Commun. 2021;12(1):6690.","journal-title":"Nat Commun"},{"issue":"4","key":"268_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/MCP.0b013e32832af07c","volume":"15","author":"GT Stathopoulos","year":"2009","unstructured":"Stathopoulos GT, Kalomenidis I. Animal models of malignant pleural effusion. Curr Opin Pulm Med. 2009;15(4):343\u201352.","journal-title":"Curr Opin Pulm Med"},{"key":"268_CR11","doi-asserted-by":"crossref","unstructured":"Skok K, Hladnik G, Grm A, Crnjac A. Malignant Pleural Effusion and Its Current Management: A Review. Med (Kaunas). 2019;55(8):490.","DOI":"10.3390\/medicina55080490"},{"issue":"7203","key":"268_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344.","journal-title":"Nature"},{"issue":"2","key":"268_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1165\/rcmb.2005-0130OC","volume":"34","author":"GT Stathopoulos","year":"2006","unstructured":"Stathopoulos GT, Zhu Z, Everhart MB, Kalomenidis I, Lawson WE, Bilaceroglu S, et al. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. Am J Respir Cell Mol Biol. 2006;34(2):142\u201350.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"268_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12935-024-03211-w","volume":"24","author":"S Ge","year":"2024","unstructured":"Ge S, Zhao Y, Liang J, He Z, Li K, Zhang G, et al. Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications. Cancer Cell Int. 2024;24(1):105.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"268_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1590\/S1807-59322008000500012","volume":"63","author":"LM Aguiar","year":"2008","unstructured":"Aguiar LM, Antonangelo L, Vargas FS, Zerbini MC, Sales MM, Uip DE, et al. Malignant and tuberculous pleural effusions: immunophenotypic cellular characterization. Clin (Sao Paulo). 2008;63(5):637\u201344.","journal-title":"Clin (Sao Paulo)"},{"issue":"5","key":"268_CR16","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.ejim.2007.09.014","volume":"19","author":"S Bielsa","year":"2008","unstructured":"Bielsa S, Salud A, Mart\u00ednez M, Esquerda A, Mart\u00edn A, Rodr\u00edguez-Panadero F, et al. Prognostic significance of pleural fluid data in patients with malignant effusion. Eur J Intern Med. 2008;19(5):334\u20139.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"268_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.amjms.2019.04.009","volume":"358","author":"J Lee","year":"2019","unstructured":"Lee J, Lee YH, Seo H, Lee H, Kim YK, Yoo SS, et al. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions. Am J Med Sci. 2019;358(2):115\u201320.","journal-title":"Am J Med Sci"},{"issue":"5","key":"268_CR18","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731\u20138.","journal-title":"J Immunol"},{"issue":"6","key":"268_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4110\/in.2014.14.6.289","volume":"14","author":"J Choi","year":"2014","unstructured":"Choi J, Lee SJ, Lee YA, Maeng HG, Lee JK, Kang YW. Reference values for peripheral blood lymphocyte subsets in a healthy korean population. Immune Netw. 2014;14(6):289\u201395.","journal-title":"Immune Netw"},{"issue":"18","key":"268_CR20","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/cells13181583","volume":"13","author":"E Arlt","year":"2024","unstructured":"Arlt E, Kindermann A, Fritsche AK, Navarrete Santos A, Kielstein H, Bazwinsky-Wutschke I. A Flow Cytometry-Based Examination of the Mouse White Blood Cell Differential in the Context of Age and Sex. Cells. 2024;13(18):1583.","journal-title":"Cells"},{"issue":"1","key":"268_CR21","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285.","journal-title":"Nat Commun"},{"key":"268_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2020.12.016","volume":"500","author":"FS Yi","year":"2021","unstructured":"Yi FS, Zhai K, Shi HZ. Helper T cells in malignant pleural effusion. Cancer Lett. 2021;500:21\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"268_CR23","doi-asserted-by":"publisher","first-page":"2371556","DOI":"10.1080\/2162402X.2024.2371556","volume":"13","author":"Y Sugita","year":"2024","unstructured":"Sugita Y, Muraoka D, Demachi-Okamura A, Komuro H, Masago K, Sasaki E, et al. Candidate tumor-specific CD8(+) T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis. Oncoimmunology. 2024;13(1):2371556.","journal-title":"Oncoimmunology"},{"issue":"2","key":"268_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41565-021-01032-w","volume":"17","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang L, Song Q, Ali M, Crowe WN, Kucera GL, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17(2):206\u201316.","journal-title":"Nat Nanotechnol"},{"key":"268_CR25","doi-asserted-by":"publisher","first-page":"104717","DOI":"10.1016\/j.critrevonc.2025.104717","volume":"211","author":"L Chen","year":"2025","unstructured":"Chen L, Yin J, Xu K, Cui Y, Zhu S, Li T, et al. Novel bioengineered drugs with immunotherapies for malignant pleural effusion: Remodulate tumor immune microenvironment and activate immune system. Crit Rev Oncol Hematol. 2025;211:104717.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"268_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","volume":"15","author":"J Hu","year":"2023","unstructured":"Hu J, Zhang L, Xia H, Yan Y, Zhu X, Sun F, et al. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. Genome Med. 2023;15(1):14.","journal-title":"Genome Med"},{"issue":"1","key":"268_CR27","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1080\/07853890.2022.2071977","volume":"54","author":"Z Xiang","year":"2022","unstructured":"Xiang Z, Deng X, He W, Yang Q, Ni L, Dehghan Shasaltaneh M, et al. Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy. Ann Med. 2022;54(1):1357\u201371.","journal-title":"Ann Med"}],"container-title":["Laboratory Animal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00268-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42826-026-00268-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42826-026-00268-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:45:00Z","timestamp":1781642700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42826-026-00268-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1186\/s42826-026-00268-8","relation":{},"ISSN":["2233-7660"],"issn-type":[{"value":"2233-7660","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}